Rare Disease Genetic Testing
                     Rare Disease Genetic Testing 
Market
Set to Reach USD 1.8 Billion by 2027 | CAGR: 10.6%
“Rare Disease Genetic Testing Market Share, Size, Trends, Industry 
Analysis Report, By Disease Type (Neurological Disorders, 
Immunological Disorders, Hematology Ailments, Endocrine & 
Metabolism Disorders, Cancer, Musculoskeletal Disorders, 
Cardiovascular Disorders, Dermatology Disorders, Others); By 
Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 
2020 – 2027”
Rare Disease Genetic Testing Market Estimate & Forecast to 2027
According to a latest report by Polaris Market Research, the global Rare Disease Genetic 
Testing market is anticipated to reach USD 1.8 Billion by 2027 registering a CAGR of 10.6% 
during the  forecast period (2020 to 2027).
The report offers in-depth insights, market share, and other vital information such as key 
trends, drivers, restraints, opportunities, and hurdles in the Rare Disease Genetic Testing 
market over the forecast period. The impact of the COVID-19 pandemic on manufacturing 
processes, unit sales, and revenues incorporated into the  Rare Disease Genetic Testing 
market projections.
A rise in technological innovations, increasing investments for improving product offerings, 
and initiations of research programs are projected to drive significant growth for the global 
Rare Disease Genetic Testing market over the forecast period.
The analysis covered in the report evaluates the Rare Disease Genetic Testing market based 
on various parameters such as manufacturing rights & patents, brand loyalty, switching 
costs,  capital investments, distribution channels, government regulations, and the impact of 
consumer preferences. This all summarized vital information will help the key decision-
makers of the industry in their decision-making process.
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 2
Rare Disease Genetic Testing Market Scope
By Disease Type By Technology By Specialty By End-Use By Region
• Neurological • Next Generation Sequencing • Molecular Genetic • Research • North America (U.S., Canada)
Disorders • Whole Exome Testing Laboratories & CROs • Europe (France, Germany, UK, 
• Immunological Sequencing • Chromosomal Genetic • Hospitals & Clinics Italy, Spain, Netherlands, 
Disorders • Whole Genome Testing • Diagnostic Austria)
• Hematology Sequencing • Biochemical Genetic Laboratories • Asia Pacific (Japan, China, India, 
Diseases • Array Technology Testing Malaysia, Indonesia. South 
• Endocrine & • PCR - based Testing Korea)
Metabolism • FISH • Latin America (Brazil, Mexico, 
Diseases • Sanger Sequencing Argentina)
• Cancer • Karyotyping • Middle East & Africa (Saudi 
• Musculoskeletal Arabia, UAE, Israel, South 
Disorders Africa)
• Cardiovascular 
Disorders
• Dermatology 
Diseases
• Others
Request for sample
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 3
Rare Disease Genetic Testing Market Estimate & Forecast to 2027
The report covers a comprehensive analysis of the Rare Disease Genetic Testing market by 
disease type, technology, specialty, end-use, and region. The report also sheds light on the 
key market segments that are major contributors in terms of revenue generation. The 
information provided in the research report is anticipated to be helpful for all the key 
stakeholders of the Rare Disease Genetic Testing market.
                                                                            Browse Complete Report
The research report prepared for the Rare Disease Genetic Testing market presents vital 
information gathered after deep analysis of the leading players from the market, including 
agreements, acquisitions & mergers, partnerships, new product launches, collaborations & 
joint ventures, research & development, and regional expansion. Major players operating in 
the Rare Disease Genetic Testing market are Strand Life Sciences, Myriad Genetics, Quest 
Diagnostics Inc., Centogene N.V., Invitae Corporation, 3billion, Inc., Eurofins Scientific, 
Baylor Genetics, Ambry Genetics, Perkin Elmer, Macrogen, Inc., Opko Health, Inc., Color 
Genomics, Inc., Health Network Laboratories, Preventiongenetics, Progenity, Inc., Fulgent 
Genetics Inc., and Laboratory Corporation of America Holdings.
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 4
Rare Disease Genetic Testing Market Size
Request for TOC
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 5
Rare Disease Genetic Testing Market Study – Engagement Options
Buy Now – Click Here!
✔Buy now & have immediate access to premium insights
Purchase Report Sections – Click Here!
✔Regional analysis
✔Segmentation analysis
Market ✔ Industry outlook
✔Competitive landscape
Speak To Analyst – Click Here!
✔Get your doubts clear
✔Schedule a call with our analyst before making any decision
Request For Sample Pages – Click Here!
✔Get free sample pages 
✔Understand report structure
✔Unmask data for validation
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 6
About Us
Polaris Market Research is a global market research and consulting company. The company 
specializes in providing exceptional market intelligence and in-depth business research 
services for a clientele spread across different enterprises. We at Polaris are obliged to serve 
our diverse customer base present across the industries of healthcare, technology, semi-
conductors, and chemicals among various other industries present around the world. We 
strive to provide our customers with updated information on innovative technologies, high 
growth markets, emerging business environments, and the latest business-centric 
applications, thereby helping them always to make informed decisions and leverage new 
opportunities. Adept with a highly competent, experienced, and highly qualified team of 
experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-
added business solutions to our customers.
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com
Copyright © Polaris Market Research & Consulting LLP 2020. All Rights Reserved 7
Thank You!
Contact Us :
Polaris Market Research
30 Wall Street
8th Floor, 
New York City, NY 10005,
United States
E mail Id: [email protected]
Phone: +1-917-985-9017